Almac Group Addresses Industry Demand For Multiparticulate Drug Products

News   Oct 12, 2015

 
Almac Group Addresses Industry Demand For Multiparticulate Drug Products
 
 
 

RELATED ARTICLES

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal Trials

News

A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.

READ MORE

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy